Top Markets
Coin of the day
Alimera Sciences, Inc. Alimera Sciences, Inc.

Alimera Sciences, Inc.

ALIM
Classificação em ações #26668
Alimera Sciences, Inc. is a pharmaceutical company focused on developing and... Alimera Sciences, Inc. is a pharmaceutical company focused on developing and commercializing ophthalmic treatments globally, including in the United States. Its primary offering, ILUVIEN, is an intravitreal implant used to manage diabetic macular edema (DME), a severe retinal disease in individuals with diabetes that can lead to profound vision loss and blindness. Additionally, ILUVIEN helps prevent relapses of recurrent non-infectious uveitis affecting the posterior segment of the eye. The company distributes its products directly and through distributors to various healthcare entities such as physician offices, pharmacies, and hospitals. Alimera also maintains a collaboration with EyePoint Pharmaceuticals US, Inc. focused on developing and marketing insert technology. This technology is designed to deliver corticosteroids to the back of the eye for treating and preventing various human eye diseases, including diabetic macular edema. Founded in 2003, Alimera Sciences is headquartered in Alpharetta, Georgia.
Preço da ação
$5.54
Última sincronização: 2024-09-18
Valor de mercado
$38.76M
Variação (1 dia)
0.00%
Variação (1 ano)
0.00%
País
US
Negociar Alimera Sciences, Inc. (ALIM)

Categoria

EPS de Alimera Sciences, Inc. (ALIM)
EPS em June 2024 TTM: $-0.28
De acordo com os últimos relatórios financeiros e o preço das ações da Alimera Sciences, Inc., o EPS atual da empresa (TTM) é $-0.28. No final de 2022, a empresa teve um EPS de $-2.59, um aumento em relação a ao EPS de 2021, que foi de $-0.66.
Histórico de EPS da Alimera Sciences, Inc. de 2006 até 2026
EPS no final de cada ano
Ano EPS Alterar
2026 (TTM) $-0.28 -64.56%
2023 $-0.79 -69.50%
2022 $-2.59 292.42%
2021 $-0.66 -36.54%
2020 $-1.04 -52.51%
2019 $-2.19 -158.40%
2018 $3.75 -176.06%
2017 $-4.93 -47.66%
2016 $-9.42 -8.90%
2015 $-10.34 -22.43%
2014 $-13.33 -45.14%
2013 $-24.30 158.24%
2012 $-9.41 -12.63%
2011 $-10.77 61.95%
2010 $-6.65 -98.48%
2009 $-437.12 -23.24%
2008 $-569.46 977.30%
2007 $-52.86 -56.02%
2006 $-120.18 0.00%
EPS de empresas semelhantes ou concorrentes